Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 650 across all filing types
Latest filing 2024-07-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a South Korean company (GemVax) regarding a 'Correction Report' (정정신고) for a 'Contract for Stock Collateral Provision Involving a Change in the Largest Shareholder'. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) to inform the public and shareholders about significant changes in the company's capital structure, specifically regarding the pledging of shares by the largest shareholder. It does not fit into categories like Earnings Release, Annual Report, or M&A, but rather falls under general regulatory disclosures regarding corporate financing and shareholding status.
2024-07-29 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from GemVax regarding the results of a securities issuance (specifically a private placement of bonds with warrants). It details the issuance amount, payment date, and type of security. This falls under the category of capital and financing updates as it reports on the completion of a financing activity.
2024-07-16 Korean
주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from GemVax & Kael, specifically detailing the decision to issue bonds with warrants (신주인수권부사채 발행결정). This type of filing is a regulatory disclosure regarding capital structure changes and financing activities. According to the provided definitions, documents related to fundraising, financing activities, or capital structure changes are classified as 'CAP'.
2024-07-12 Korean
주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the decision to issue bonds with warrants (신주인수권부사채 발행결정). This type of filing is a regulatory requirement for capital structure changes and financing activities in the Korean market. It falls under the 'Capital/Financing Update' category as it details the issuance of debt instruments and associated warrants.
2024-07-12 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (GemVax) regarding a 'Correction Report' (정정신고) for a 'Pledge of Shares' (주식담보제공 계약). It details the modification of a loan maturity date and provides a comprehensive table of existing share pledges. This type of disclosure is a standard regulatory requirement for listed companies to inform the market about changes in the collateralization of shares held by major shareholders. It does not fit into specific categories like Earnings Release, Annual Report, or M&A, and is therefore classified as a Regulatory Filing.
2024-07-11 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule report). It details changes in share ownership, including corrections to previous filings. This falls under the category of Major Shareholding Notification.
2024-07-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.